
ERYTECH Pharma S.A. ERYP
Annual report 2022
added 12-21-2024
ERYTECH Pharma S.A. Historical Prices 2011-2026 | ERYP
Annual Historical Prices ERYTECH Pharma S.A.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.78 | 2.35 | 9.23 | 7.38 | 6.77 | 22 | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22 | 0.78 | 8.09 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
BioNTech SE
BNTX
|
91.2 | $ 96.98 | -6.26 % | $ 27.2 B | ||
|
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | ||
|
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | ||
|
Burford Capital Limited
BUR
|
10.6 | $ 5.16 | 4.56 % | $ 820 M | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B | ||
|
Cerus Corporation
CERS
|
2.6 | $ 2.73 | 34.49 % | $ 520 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
19.3 | $ 21.96 | -2.2 % | $ 3.64 B | ||
|
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | ||
|
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
74.2 | - | - | $ 96.9 B | ||
|
Atreca
BCEL
|
1.27 | - | -11.76 % | $ 5.79 M | ||
|
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | ||
|
Calithera Biosciences
CALA
|
13.3 | - | -10.95 % | $ 876 K | ||
|
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | ||
|
CymaBay Therapeutics
CBAY
|
32.3 | - | - | $ 3.45 B | ||
|
ChemoCentryx
CCXI
|
26.9 | - | - | $ 3.74 B | ||
|
Cardiff Oncology
CRDF
|
1.74 | $ 1.71 | -1.45 % | $ 114 M | ||
|
Caladrius Biosciences
CLBS
|
0.43 | - | -16.75 % | $ 25.8 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
2.44 | - | - | $ 231 M | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
14.1 | - | - | $ 2.18 B | ||
|
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | ||
|
Editas Medicine
EDIT
|
2.32 | $ 2.92 | -2.83 % | $ 259 M | ||
|
Dynavax Technologies Corporation
DVAX
|
13.3 | - | - | $ 2.02 B | ||
|
Edesa Biotech
EDSA
|
1.9 | $ 17.54 | -4.02 % | $ 56.1 M | ||
|
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 3.0 | -5.96 % | $ 4.94 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
2.11 | - | -9.21 % | $ 2.55 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
2.84 | - | -5.68 % | $ 8.28 M | ||
|
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | ||
|
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | ||
|
Evogene Ltd.
EVGN
|
0.81 | $ 0.79 | 1.66 % | $ 27.9 M | ||
|
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
0.22 | - | 17.91 % | $ 11.1 M |